107 related articles for article (PubMed ID: 3179208)
1. The lateral spread of clobetasol 17-propionate in the stratum corneum in vivo.
Ashworth J; Watson WS; Finlay AY
Br J Dermatol; 1988 Sep; 119(3):351-8. PubMed ID: 3179208
[TBL] [Abstract][Full Text] [Related]
2. The effect of the vehicle formulation on the stratum corneum penetration characteristics of clobetasol 17-propionate in vivo.
Watson WS; Finlay AY
Br J Dermatol; 1988 Apr; 118(4):523-30. PubMed ID: 3377973
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous absorption of clobetasol propionate from novel ointment and cream formulations.
Harding SM; Sohail S; Busse MJ
Clin Exp Dermatol; 1985 Jan; 10(1):13-21. PubMed ID: 3987081
[No Abstract] [Full Text] [Related]
4. Bioavailability of clobetasol propionate-quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping.
Weigmann H; Lademann J; v Pelchrzim R; Sterry W; Hagemeister T; Molzahn R; Schaefer M; Lindscheid M; Schaefer H; Shah VP
Skin Pharmacol Appl Skin Physiol; 1999; 12(1-2):46-53. PubMed ID: 10325583
[TBL] [Abstract][Full Text] [Related]
5. In vitro penetration through the skin layers of topically applied glucocorticoids.
Carrer V; Alonso C; Oliver MA; Coderch L
Drug Test Anal; 2018 Oct; 10(10):1528-1535. PubMed ID: 29788546
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of clobetasol propionate in different vehicles.
Franz TJ; Lehman PA; Feldman SR; Spellman MC
Skin Pharmacol Appl Skin Physiol; 2003; 16(4):212-6. PubMed ID: 12784060
[TBL] [Abstract][Full Text] [Related]
7. Unexpected clobetasol propionate profile in human stratum corneum after topical application in vitro.
Mueller B; Anissimov YG; Roberts MS
Pharm Res; 2003 Nov; 20(11):1835-7. PubMed ID: 14661929
[TBL] [Abstract][Full Text] [Related]
8. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.
Korting HC; Vieluf D; Kerscher M
Eur J Clin Pharmacol; 1992; 42(2):159-61. PubMed ID: 1618247
[TBL] [Abstract][Full Text] [Related]
9. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of clobetasol spray: factors beyond patient compliance.
Bhutani T; Koo J; Maibach HI
J Dermatolog Treat; 2012 Feb; 23(1):11-5. PubMed ID: 21254848
[TBL] [Abstract][Full Text] [Related]
11. Relation of application time to bioactivity of a potent topical glucocorticoid formulation.
Stoughton RB; Wullich K
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1038-41. PubMed ID: 2370328
[TBL] [Abstract][Full Text] [Related]
12. A novel foam vehicle for delivery of topical corticosteroids.
Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate ointment reduces inflammation after cryotherapy.
Hindson TC; Spiro J; Scott LV
Br J Dermatol; 1985 May; 112(5):599-602. PubMed ID: 3890918
[TBL] [Abstract][Full Text] [Related]
14. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
Novak E; Francom SF; Schlagel CA
Clin Ther; 1983; 6(1):59-71. PubMed ID: 6370438
[TBL] [Abstract][Full Text] [Related]
15. Determination of the formation of the stratum corneum reservoir for two different corticosteroid formulations using tape stripping combined with UV/VIS spectroscopy.
Pelchrzim Rv; Weigmann HJ; Schaefer H; Hagemeister T; Linscheid M; Shah VP; Sterry W; Lademann J
J Dtsch Dermatol Ges; 2004 Nov; 2(11):914-9. PubMed ID: 16281609
[TBL] [Abstract][Full Text] [Related]
16. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects.
Au WL; Skinner MF; Benfeldt E; Verbeeck RK; Kanfer I
Skin Pharmacol Physiol; 2012; 25(1):17-24. PubMed ID: 21860254
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of clobetasol 17-propionate and traimcinolone acetonide].
Esser B
Z Hautkr; 1979 Oct; 54(20):893-7. PubMed ID: 392970
[No Abstract] [Full Text] [Related]
18. Evaluation of in vivo bioequivalence methodology for topical clobetasol 17-propionate based on pharmacodynamic modeling using Chinese skin.
Tsai JC; Cheng CL; Tsai YF; Sheu HM; Chou CH
J Pharm Sci; 2004 Jan; 93(1):207-17. PubMed ID: 14648650
[TBL] [Abstract][Full Text] [Related]
19. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
Priestley GC
Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
[TBL] [Abstract][Full Text] [Related]
20. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; van de Kerkhof PC
Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
